Virginia cop claims AbbVie drug triggered his psychosis; Novartis nabs Bexsero rec in Australia; FDA clears Roche HPV test as Pap replacement;

@FiercePharma: Yesterday's top-read special report: The top 10 pharma companies by 2013 revenue. Read | Follow @FiercePharma

@TracyStaton: Uh-oh for Merck animal health: Hundreds more Zilmax-fed cattle died than Merck reported to FDA. Story via Reuters | Follow @TracyStaton

@EricPFierce: Sun Pharma plant joins FDA village of the banned. Story via FiercePharmaManufacuring | Follow @EricPFierce

@CarlyHFierce: Missed yesterday's issue of FiercePharmaMarketing? Got you covered. | Follow @CarlyHFierce

> A Virginia Beach, VA, police officer sued AbbVie ($ABBV) and its former parent Abbott Laboratories ($ABT), claiming that its antibiotic Biaxin triggered his psychotic episode, during which he stabbed two firefighters. Report

> Novartis ($NVS) won a clinical recommendation in Australia for routine use of its Bexsero vaccine against meningitis B in infants and adolescents. Report

> An FDA panel recommended Roche's ($RHHBY) human papilloma virus diagnostic test as an alternative to the common cervical cancer screening method, the Pap test. Release

> Belgium-based UCB launched its anti-inflammatory drug Cimzia (certolizumab) in the U.K. and Ireland as a treatment for psoriatic arthritis. Report

> Scotland's cost-effectiveness panel decided to recommend Sanofi's ($SNY) colon cancer treatment Zaltrap after all. Report

Medical Device News

@FierceMedDev: Add debt restructuring to Quest Diagnostics' numerous moves to improve things. Story | Follow @FierceMedDev

@MarkHFierce: Philips ventilator recall gets slapped with the FDA's Class I recall status--its most serious designation. More | Follow @MarkHFierce

@MichaelGFierce: NeuroDerm preps for Parkinson's patch PhII trial. Read in FierceDrugDelivery. | Follow @MichaelGFierce

@EmilyWFierce: Roche gets glowing reviews from FDA panel for frontline HPV test. Article | Follow @EmilyWFierce

> Quest Diagnostics is proposing a $600M debt refinancing. More

> Vaginal mesh lawsuits are escalating in Scotland. Piece

Biotech News

@FierceBiotech: Sage snags $38M from A-list VCs to bankroll its seizure drugs. More | Follow @FierceBiotech

@JohnCFierce: Circassia's record-busting $332M IPO inspires hopes of U.K. renaissance. News | Follow @JohnCFierce

@DamianFierce: Vectura bags respiratory biotech Activaero for $181M. Story | Follow @DamianFierce

@EmilyMFierce: Despite progress, tuberculosis persists in West European cities. Piece via Reuters | Follow @EmilyMFierce

> GlaxoSmithKline maps a route to regulators with positive PhIII asthma data. Article

> Tesaro pays $17M to team with AnaptysBio on cancer immunotherapies. More

Pharma Manufacturing News

> CMO born from $2.6 billion merger comes on the scene as DPx. Story

> Sun Pharma plant joins the FDA list of banned Indian facilities. News

> FDA says Indian drugmaker made up data for API tests. Piece

> Bayer expands German plants as it preps for new hemophilia treatments. More

> Hikma hits the jackpot with doxycycline shortage. Coverage

> Pharma cargo theft takes new spike. Brief

Vaccines News

> Daiichi misses H5N1 vaccine production goal after low yields slash output. Story

> Analysts offer mixed reactions to Pfizer's Prevnar 13 data close-up. Article

> Northwest Bio, NewLink proceed with cancer vax trials to mixed reviews. News

> ImmusanT waits on early clinical data for its celiac disease vaccine. Story

> Study: Vaccinating diabetics against flu cuts risk of death by 28%. Article

> U.K. mulls adopting a 2-dose model for HPV vaccination. Brief

And Finally... "Love hormone" oxytocin could help treat anorexia nervosa, researchers said. Report